BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 34823004)

  • 1. Modulating CRISPR/Cas9 genome-editing activity by small molecules.
    Chen S; Chen D; Liu B; Haisma HJ
    Drug Discov Today; 2022 Apr; 27(4):951-966. PubMed ID: 34823004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides.
    Ding X; Seebeck T; Feng Y; Jiang Y; Davis GD; Chen F
    CRISPR J; 2019 Feb; 2():51-63. PubMed ID: 31021236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient genome editing in wheat using Cas9 and Cpf1 (AsCpf1 and LbCpf1) nucleases.
    Kim D; Hager M; Brant E; Budak H
    Funct Integr Genomics; 2021 Jul; 21(3-4):355-366. PubMed ID: 33710467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small Molecules for Enhancing the Precision and Safety of Genome Editing.
    Shin S; Jang S; Lim D
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
    Batzir NA; Tovin A; Hendel A
    Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR Mediated Genome Engineering and its Application in Industry.
    Kaboli S; Babazada H
    Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional Control of CRISPR/Cas9 Function.
    Zhou W; Deiters A
    Angew Chem Int Ed Engl; 2016 Apr; 55(18):5394-9. PubMed ID: 26996256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Industrial Biotechnology Using CRISPR-Cas Systems.
    Donohoue PD; Barrangou R; May AP
    Trends Biotechnol; 2018 Feb; 36(2):134-146. PubMed ID: 28778606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery and development of the CRISPR system in applications in genome manipulation.
    Lau V; Davie JR
    Biochem Cell Biol; 2017 Apr; 95(2):203-210. PubMed ID: 28103055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management.
    Allemailem KS; Alsahli MA; Almatroudi A; Alrumaihi F; Alkhaleefah FK; Rahmani AH; Khan AA
    Cancer Commun (Lond); 2022 Dec; 42(12):1257-1287. PubMed ID: 36209487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.